Lupus & antiphospholipid syndrome

Cost-of-illness changes before and after the diagnosis of systemic lupus erythematosus: a nationwide, population-based observational study in Korea

Rheumatology (Oxford)Published Population-based matched cohort study

Main finding · Annual direct healthcare costs per personResult — go to the resultFold greater 7.7

Authors' conclusion

Patients with SLE incurred significantly higher direct healthcare costs than subjects without SLE during the first year after diagnosis. Disease severity, older age, major organ involvements and comorbidities were associated with increased healthcare costs.

Study context

Population
Patients with incident systemic lupus erythematosus (SLE) diagnosed 2008–2018, Korean National Health Insurance database, and matched controlsmatched cohort
Participants
11,173 vs 45,500
Exposure
Incident SLE vs matched controls without SLE; severe vs mild SLE
  • SLEn = 11,173
  • Without SLEn = 45,500reference
Outcome
Annual direct healthcare costs per person, 5 years before and after SLE diagnosis
Methodological detailsnationwide, age-, sex- and calendar month-matched (1:4) controls, regression analysis
  • Nationwide
  • Age-, sex- and calendar month-matched (1:4) controls
  • Regression analysis

Main finding

Annual direct healthcare costs per person · first year after diagnosis

Fold greater

7.7

By group

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeFold higher annual costs (95% CI)
Annual costs, severe vs mild SLE · year after diagnosis3.284 (3.075–3.507)

Factors associated with higher annual direct healthcare costs (times) · first year after diagnosis

Age 60-69
1.119 (1.034, 1.211)
Age 70-79
1.470 (1.342, 1.611)
LN
1.794 (1.711, 1.881)
ILD
1.435 (1.258, 1.638)
Avascular necrosis
6.208 (4.541, 8.487)
CKD
1.858 (1.673, 2.064)
  • 95% CI

Original publication

Cost-of-illness changes before and after the diagnosis of systemic lupus erythematosus: a nationwide, population-based observational study in Korea. Rheumatology (Oxford). Published 9 December 2023. doi:10.1093/rheumatology/kead664

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.